Literature DB >> 15828171

Rapid microassays for clindamycin and gentamicin when present together and the effect of pH and of each on the antibacterial activity of the other.

L D Sabath, I Toftegaard.   

Abstract

Gentamicin was measured in the presence of clindamycin by using as the assay organism a strain of Staphylococcus aureus that was resistant to clindamycin; clindamycin was measured in the presence of gentamicin by using Clostridium perfringens as the assay organism. Both assays were in agar diffusion systems, were rapid (2 to 4 h), and had errors of less than 10%. Neither antibiotic antagonized or synergized with the other against a variety of organisms. The pK of clindamycin was 7.3, and the pK of gentamicin was 8.2. Gentamicin was 100 or more times as active in alkaline medium against both gram-positive and gram-negative organisms, but clindamycin showed a striking pH effect on activity only with gram-positive organisms.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15828171      PMCID: PMC429047          DOI: 10.1128/AAC.6.1.54

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Treatment of anaerobic infections with lincomycin and clindamycin.

Authors:  J G Bartlett; V L Sutter; S M Finegold
Journal:  N Engl J Med       Date:  1972-11-16       Impact factor: 91.245

2.  Letter: Bacteroides infections.

Authors:  D A Leigh
Journal:  Lancet       Date:  1973-11-10       Impact factor: 79.321

3.  Erythromycin and alkalinisation of urine in the treatment of urinary-tract infections due to gram-negative bacilli.

Authors:  S H Zinner; L D Sabath; J I Casey; M Finland
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

4.  Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.

Authors:  L D Sabath; D A Gerstein; P B Loder; M Finland
Journal:  J Lab Clin Med       Date:  1968-12

5.  Effectiveness of erythromycin plus alkalinization and of nitrofurantoin in the treatment of urinary tract infections.

Authors:  J Klastersky; L Debusscher; D Daneau
Journal:  Curr Ther Res Clin Exp       Date:  1971-07

6.  Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.

Authors:  L D Sabath; J I Casey; P A Ruch; L L Stumpf; M Finland
Journal:  J Lab Clin Med       Date:  1971-09

7.  Effect of pH on the activity of erythromycin against 500 isolates of gram-negative bacilli.

Authors:  V Lorian; L D Sabath
Journal:  Appl Microbiol       Date:  1970-11

8.  Enhancing effect on alkalinization of the medium on the activity of erythromycin against gram-negative bacteria.

Authors:  L D Sabath; V Lorian; D Gerstein; P B Loder; M Finland
Journal:  Appl Microbiol       Date:  1968-09

9.  Simplified assay for gentamicin in the presence of other antibiotics.

Authors:  D V Alcid; S J Seligman
Journal:  Antimicrob Agents Chemother       Date:  1973-05       Impact factor: 5.191

  9 in total
  19 in total

1.  Parenteral clindamycin phosphate: pharmacology with normal and abnormal liver function and effect on nasal staphylococci.

Authors:  D N Williams; K Crossley; C Hoffman; L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

2.  Evaluation of the 10-micrograms clindamycin disk for susceptibility testing of anaerobes by the aerobically incubated thioglycolate broth disk method.

Authors:  K L Toohey; T A Kurzynski; R F Schell; R J Birk; R J Zabransky
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

3.  Chemotherapy of an experimental Bacteroides fragilis infection in mice.

Authors:  C B Walker; D Nitzan; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

4.  X-ray excited luminescent chemical imaging (XELCI) for non-invasive imaging of implant infections.

Authors:  Donald Benza; Unaiza Uzair; Yash Raval; Tzuen-Rong J Tzeng; Caleb J Behrend; Jeffrey N Anker
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-02-23

5.  Bioassay of antibiotics in body fluids from patients receiving cancer chemotherapeutic agents.

Authors:  D N Wright; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

6.  Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease.

Authors:  M I Thompson; M E Russo; B J Saxon; E Atkin-Thor; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

7.  Simple assay for clindamycin in the presence of aminoglycosides.

Authors:  F R Ervin; W E Bullock
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

8.  Effect of clindamycin on the in vitro activity of amikacin and gentamicin against gram-negative bacilli.

Authors:  S H Zinner; R B Provonchee; K S Elias; G Peter
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

9.  Concurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly(anhydride-esters).

Authors:  Michelle L Johnson; Kathryn E Uhrich
Journal:  J Biomed Mater Res A       Date:  2009-12       Impact factor: 4.396

10.  Effect of clindamycin on aminoglycoside activity in a murine model of invasive Escherichia coli infection.

Authors:  E Ekwo; G Peter
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.